Innovassynth Technologies (India)
INOVSYNTHBSE

Innovassynth Technologies (India)

₹65.16-3.71 (5.39%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
64.75
Today’s high
70.00
52 week low
45.01
52 week high
125.65
Open price
68.90
Previous close
68.87
Live volume
44,750
Lower circuit
52.13
Upper circuit
78.19

Fundamentals

Market Cap
₹640Cr
ROE
-15.71%
P/E Ratio(TTM)
-124.46
EPS(TTM)
-0.51
P/B Ratio
4.34
Dividend Yield
0.00%
Industry P/E
42.93
Book Value
15.87
Debt to Equity
0.16
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹22.08
+25.60%
Profit (Cr)
-₹7.80
+45.38%
-200204060
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)-57%

About

Innovassynth Investments Limited is a public investment holding company, which was established on February 15, 2008, with its business operations centered in India. The company's philosophy is committed to achieving high standards of corporate governance, holding management accountable to all stakeholders through fairness, ethics, and transparency. Its primary activity is investing in its associate, Innovassynth Technologies (India) Limited (ITIL), an internationally recognized manufacturer of specialty chemicals like nucleosides and amides. This associate, ITIL, is a research-driven organization focused on developing and manufacturing specialty chemicals and pharmaceutical intermediates through contract research and custom synthesis. A niche focus for the associate is producing protected nucleosides and modified phosphonamidites, which are key components for therapeutic and diagnostic oligonucleotide applications globally. Since the performance of ITIL is the key factor for its own sustainability, the company maintains an optimistic outlook on its associate's performance.;
CEO/MD
Dr. Hardik Joshipura
Founded in
2008
BSE symbol
533315

Shareholding Pattern

Jun '25
Sep '25
Dec '25
Jan '26
Mar '26
Promoters
73.70%
Retail And Others
23.46%
Foreign Institutions
1.39%
Other Domestic Institutions
1.36%
Mutual Funds
0.10%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
AvenuesAICCAVENUE
₹14.05
+0.10 (0.72%)
L
    H
    4,897.4718.721.17
    ₹74.66
    +0.12 (0.16%)
    L
      H
      1,655.696.171.22
      ₹76.46
      -0.95 (1.23%)
      L
        H
        1,349.3911.031.29
        ₹63.00
        0.00 (--)
        L
          H
          1,308.25161.545.83
          2026

          29
          Apr
          Rights Entitlement
          Ex date
          3:13
          Ratio

          3 rights eligible for every 13 existing shares held
          Ratio3:13
          Offer price₹40.00
          Ex date29 Apr ‘26
          Record date29 Apr ‘26
          Announcement date23 Apr ‘26

          23
          Apr
          Rights Entitlement
          Announced
          3:13
          Ratio

          3 rights eligible for every 13 existing shares held
          Ratio3:13
          Offer price₹40.00
          Ex date29 Apr ‘26
          Record date29 Apr ‘26
          Announcement date23 Apr ‘26
          10
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks